When did Vir Biotechnology, Inc. report Q4 2024 earnings?

Vir Biotechnology, Inc. (VIR) reported Q4 2024 earnings on February 26, 2025 after market close.

What were Vir Biotechnology, Inc.'s Q4 2024 revenue and EPS?

Vir Biotechnology, Inc. reported revenue of $12.4M and eps of $-0.76 for Q4 2024.

Did Vir Biotechnology, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $8.1M by $4.2M. EPS beat the consensus estimate of $-0.85 by $0.09.

Where can I find Vir Biotechnology, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001628280-25-008245) directly on SEC EDGAR. The filing index links above go to sec.gov.

Vir Biotechnology, Inc. VIR Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$12.4MBeat by $4.2M

EPS-$0.76Beat by $0.09

Revenue estimate$8.1M

EPS estimate-$0.85

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$135.9M

EPS estimate$0.33

Financials

Q4 2024

Income statement

See full

Revenue$12.4M-26.3%

Gross profit$11.7M-26.9%

Operating income-$117.2M+15.7%

Net income-$104.6M+9.8%

EPS (diluted)-$0.76+11.6%

Balance sheet

See full

Cash & equivalents$318.7M+22.0%

Total debt$97.9M-21.4%

Total equity$1.2B-27.7%

Total assets$1.4B-27.1%

Cash flow

See full

Operating cash flow-$87.6M+18.8%

CapEx$2.0M+30.0%

Free cash flow-$89.6M+18.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.01B-25.4%

Enterprise value$790.06M-35.1%

P/S13.6×-2.1×

Profitability

See full

Gross margin98.9%+2.1pp

Operating margin-791.3%-2.7pp

Net margin-703.4%-10.1pp

FCF margin-611.4%-156pp

Returns & leverage

See full

Return on equity-38.1%+6.0pp

Debt / equity0.1×0.0×

Current ratio8.7×-0.3×

Versus estimates

Revenue

Q1 2026-$29.0KMiss by $55.5M Q4 2025$64.1MBeat by $44.2M Q3 2025$240.0KMiss by $19.7M Q2 2025$1.2MMiss by $1.5M Q1 2025$1.8MMiss by $6.8M

Q4 2024$12.4MBeat by $4.2M

Diluted EPS

Q1 2026-$0.85Miss by $0.84 Q4 2025-$0.31Beat by $0.11 Q3 2025-$1.17Miss by $0.47 Q2 2025-$0.80Miss by $0.08 Q1 2025-$0.88Miss by $0.05

Q4 2024-$0.76Beat by $0.09

Ask the moment Vir Biotechnology, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Vir Biotechnology, Inc. report Q4 2024 earnings?: Vir Biotechnology, Inc. (VIR) reported Q4 2024 earnings on February 26, 2025 after market close.
What were Vir Biotechnology, Inc.'s Q4 2024 revenue and EPS?: Vir Biotechnology, Inc. reported revenue of $12.4M and eps of $-0.76 for Q4 2024.
Did Vir Biotechnology, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $8.1M by $4.2M. EPS beat the consensus estimate of $-0.85 by $0.09.
Where can I find Vir Biotechnology, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001628280-25-008245) directly on SEC EDGAR. The filing index links above go to sec.gov.